E-Book, Englisch, 714 Seiten, ePub
Tsementzis Differential Diagnosis in Neurology and Neurosurgery
2. Auflage 2019
ISBN: 978-3-13-258137-1
Verlag: Thieme
Format: EPUB
Kopierschutz: 6 - ePub Watermark
A Clinician's Pocket Guide
E-Book, Englisch, 714 Seiten, ePub
ISBN: 978-3-13-258137-1
Verlag: Thieme
Format: EPUB
Kopierschutz: 6 - ePub Watermark
Now in a greatly expanded and updated new edition: The essential pocketbook for rapid and correct differentiation and interpretation of signs and symptoms of neurological and neurosurgical diseases and conditions.
Key Features:
- Exhaustive range of neurologic and neurosurgical disease and conditions covered
- Vital information presented in short texts, high-yield lists, and concise tables, for maximum efficiency in diagnostic work-ups
- Clinical and neuroimaging findings, guidelines and classifications, summarized in readily accessible tabular form
- Statistic overviews (common vs. rare, etc.) help guide diagnostic thought processes
- Special chapters highlight epidemiology, pediatric disorders, neuroradiology
is ideal as a quick reference in your daily practice, or as an exam preparation guide. This wealth of easily accessed information makes it invaluable to experienced practitioners (especially ER physicians) and to novices alike.
This book includes complimentary access to a digital copy on https://medone.thieme.com.
Zielgruppe
Ärzte
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
1 Epidemiological Characteristics of Neurological Diseases
2 Neuroradiology
3 Developmental—Acquired Anomalies and Pediatric Disorders
4 Cranial Nerve Disorders
5 Neuro-Ophthalmology
6 Intracranial Tumors
7 Demyelinating Disease and Brain Atrophy
8 Cerebrovascular Disease (Stroke)
9 Spinal Disorders
10 Peripheral Nerve Disorders
11 Movement Disorders
12 Neurotrauma
13 Infections of the Central Nervous System
14 Pain
15 Neurorehabilitation
1 Epidemiological Characteristics of Neurological Diseases
1.1 Prevalence of Neurological Diseases
1.2 Epidemiology of Worldwide Neurological Disorders
In order to improve the understanding of the global burden of neurologic conditions, the Public Health Agency of Canada launched the National Population Health Study of Neurological Conditions in 2009. One of its many aims was to examine the epidemiology, including the incidence and prevalence, of 15 common neurologic conditions. This effort involved the review of 65,529 abstracts and 4,650 full-text articles, with 1,242 research studies. In the following tables, the overall worldwide pooled prevalence or incidence data from the systemic reviews of neurologic conditions are presented. The table shows differences that exist. For example, in the Canadian systematic review of the epidemiology of epilepsy, the incidence was highest in Africa at 215.00 per 100,000 person-years, followed by South America at 162.45 per 100,000 person-years. The incidence of epilepsy in North America was 23.29 per 100,000 person-years and it was 42.63 per 100,000 person-years in Europe. These differences in incidence between continents are most likely attributable to the geographic differences in risk factors for epilepsy such as the high prevalence of central nervous system (CNS) infections (i.e., neurocysticercosis) in many developing countries compared to the developed countries. For many conditions, data on the prevalence or incidence of neurologic conditions in Africa and South America were scarce or unavailable, limiting the possibility of drawing firm conclusions in these areas.
Neurological condition | Overall pooled worldwide prevalence or incidence | Region-specific prevalence or incidence |
Dementia | Prevalence (community-based, age 65+) | Prevalence (community-based, age 65+) |
4,628 per 100,000 persons | Asia 4,038 per 100,000 persons |
Incidence (community-based, 65+) | Europe 6,758 per 100,000 persons |
4,169 per 100,000 persons | North America 5,097 per 100,000 persons |
South America 3,668 per 100,000 persons |
Incidence (community-based, age 65+) |
Africa 1,350 per 100,000 persons |
Asia 870 per 100,000 persons |
Australia 1,289 per 100,000 persons |
Europe 2,317 per 100,000 persons |
North America 5,830 per 100,000 persons |
Tourette syndrome | Prevalence (in children) | Region specific analysis not performed |
770 per 100,000 persons |
Epilepsy | Prevalence (active epilepsy) | Prevalence (community-based, age 65+) |
596 per 100,000 persons | Africa 863 per 100,000 persons |
Incidence (active epilepsy) | Asia 495 per 100,000 persons |
51.32 per 100,000 persons | Europe 457 per 100,000 persons |
Incidence | North America 5,097 per 100,000 persons |
49.06 per 100,000 persons | South America 934 per 100,000 persons |
Incidence (active epilepsy) |
Africa 78.39 per 100,000 person-years |
Asia 37.56 per 100,000 person-years |
Europe 43.87 per 100,000 person-years |
North America 42.48 per 100,000 person-years |
South America 119.78 per 100,000 person-years |
Parkinson disease | Prevalence | Prevalence |
315 per 100,000 persons | Asia 337 per 100,000 persons |
Incidence | Africa 77 per 100,000 persons |
Females 36.5 per 100,000 person-years | North America/Europe/Australia 1,398 per 100,000 persons |
Males 65.5 per 100,000 person-years | South America 1,046 per 100,000 persons |
Cerebral palsy | Prevalence | Region specific analysis not performed |
221 per 100,000 live births |
Traumatic brain injury | Incidence (all age groups) | Incidence (all age groups) |
211.35 per 100,000 persons | Asia 380.35 per 100,000 persons |
Australia 414.56 per 100,000 persons |
Europe 227.74 per 100,000 persons |
North America 167.87 per 100,000 persons |
Hydrocephalus | Prevalence (infants) | Region specific analysis not performed |
135 per 100,000 persons |
Spina bifida | Prevalence | Prevalence |
46.20 per 100,000 persons | Africa 78.81 per 100,000 persons |
Asia 66.36 per 100,000 persons |
Australia 48.11 per 100,000 persons |
Europe 66.23 per 100,000 persons |
North America 35.72 per 100,000 persons |
South America 30.37 per 100,000 persons |
Brain tumors | Incidence | Region-specific analysis not performed |
10.82 per 100,000 person-years |
Cervical dystonia | Prevalence | Prevalence |
4.98 per 100,000 persons | Japan 2.52 per 100,000 persons |
Europe 6.71 per 100,000 persons |
Duchene muscular dystrophy | Prevalence (males) | Region specific analysis not performed |
4.78 per 100,000 persons |
Spinal cord injury | Incidence (excluding prehospital mortality) | Incidence (excluding prehospital mortality) |
2.88 per 100,000 persons | Europe/Asia/Australia 2.24 per 100,000 persons |
Incidence (including prehospital mortality) | North America 4.23 per 100,000 persons |
5.13 per 100,000 persons |
Huntington disease | Prevalence | Prevalence |
2.71 per 100,000 persons | Asia 0.40 per 100,000 persons |
Incidence | North America/Europe/Australia 5.7 per 100,000... |